Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alejandro Rabinstein

Showing results (21-30 of 67) with videos related to

Pageof 7
Sort By:
Advances in Neurology|June 19, 2002
Movement disordersAlireza Minagar, Alejandro Rabinstein, Lisa M Shulman, et al.
Neurocritical Care|August 1, 2012
Cognitive decline and hypersomnolence: thalamic manifestations of a tentorial dural arteriovenous fistula (dAVF)Neha Morparia, Gary Miller, Alejandro Rabinstein, et al.
World Neurosurgery|May 15, 2016
Mortality Rates After Emergent Posterior Fossa Decompression for Ischemic or Hemorrhagic Stroke in Older PatientsRoss C Puffer, Christopher Graffeo, Alejandro Rabinstein, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|September 25, 2012
Capsular warning syndrome and crescendo lacunar strokes after atherosclerotic stenosis of the recurrent artery of HeubnerJosé E Cohen, Alejandro Rabinstein, John M Gomori, et al.
Lancet (London, England)|April 8, 2015
Diagnosis of reversible causes of coma - Authors' replyJonathan A Edlow, Alejandro Rabinstein, Stephen J Traub, et al.
Neurology|May 11, 2016
Clinical Reasoning: Proptosis, headache, and fever in a healthy young womanJosé Orquera, Daniel Agustín Godoy, Réza Behrouz, et al.
Lancet (London, England)|April 29, 2014
Diagnosis of reversible causes of comaJonathan A Edlow, Alejandro Rabinstein, Stephen J Traub, et al.
Radiology|June 24, 2015
Recently Published Stroke Trials: What the Radiologist Needs to KnowWaleed Brinjikji, Alejandro Rabinstein, Harry J Cloft, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|December 19, 2012
Dosing of tissue plasminogen activator often differs from 0.9 mg/kg, but does not affect the outcomePetr Aulicky, Alejandro Rabinstein, Raymond C S Seet, et al.
Neurocritical Care|February 14, 2014
Completing the apnea test: decline in complicationsSudhir Datar, Jennifer Fugate, Alejandro Rabinstein, et al.
Pageof 7

Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
Advances in Neurology|June 19, 2002
Movement disordersAlireza Minagar, Alejandro Rabinstein, Lisa M Shulman, et al.
Neurocritical Care|August 1, 2012
Cognitive decline and hypersomnolence: thalamic manifestations of a tentorial dural arteriovenous fistula (dAVF)Neha Morparia, Gary Miller, Alejandro Rabinstein, et al.
World Neurosurgery|May 15, 2016
Mortality Rates After Emergent Posterior Fossa Decompression for Ischemic or Hemorrhagic Stroke in Older PatientsRoss C Puffer, Christopher Graffeo, Alejandro Rabinstein, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|September 25, 2012
Capsular warning syndrome and crescendo lacunar strokes after atherosclerotic stenosis of the recurrent artery of HeubnerJosé E Cohen, Alejandro Rabinstein, John M Gomori, et al.
Lancet (London, England)|April 8, 2015
Diagnosis of reversible causes of coma - Authors' replyJonathan A Edlow, Alejandro Rabinstein, Stephen J Traub, et al.
Neurology|May 11, 2016
Clinical Reasoning: Proptosis, headache, and fever in a healthy young womanJosé Orquera, Daniel Agustín Godoy, Réza Behrouz, et al.
Lancet (London, England)|April 29, 2014
Diagnosis of reversible causes of comaJonathan A Edlow, Alejandro Rabinstein, Stephen J Traub, et al.
Radiology|June 24, 2015
Recently Published Stroke Trials: What the Radiologist Needs to KnowWaleed Brinjikji, Alejandro Rabinstein, Harry J Cloft, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|December 19, 2012
Dosing of tissue plasminogen activator often differs from 0.9 mg/kg, but does not affect the outcomePetr Aulicky, Alejandro Rabinstein, Raymond C S Seet, et al.
Neurocritical Care|February 14, 2014
Completing the apnea test: decline in complicationsSudhir Datar, Jennifer Fugate, Alejandro Rabinstein, et al.
Pageof 7